Drug Information
| Drug General Information | Top | |||
|---|---|---|---|---|
| Drug ID |
D0SQ8R
|
|||
| Former ID |
DIB001017
|
|||
| Drug Name |
V-710
|
|||
| Synonyms |
Vaccine (Staphylococcus aureus), Intercell; Vaccine (Staphylococcus aureus), Merck & Co; Iron surface determinant B-based vaccine (Staphylococcus aureus infection), Merck & Co; IsdB-based vaccine (Staphylococcus aureus infection), Merck & Co
Click to Show/Hide
|
|||
| Drug Type |
Vaccine
|
|||
| Indication | Staphylococcus infection [ICD-11: 1B5Y] | Phase 2/3 | [1] | |
| Company |
Intercell AG
|
|||
| Target and Pathway | Top | |||
|---|---|---|---|---|
| Target(s) | Staphylococcus Iron-regulated surface determinant B (Stap-coc isdB) | Target Info | . | [2] |
| References | Top | |||
|---|---|---|---|---|
| REF 1 | ClinicalTrials.gov (NCT00518687) Efficacy, Immunogenicity, and Safety of a Single Dose of V710 in Adult Patients Scheduled for Cardiothoracic Surgery (V710-003 AM2). U.S. National Institutes of Health. | |||
| REF 2 | Effect of an investigational vaccine for preventing Staphylococcus aureus infections after cardiothoracic surgery: a randomized trial. JAMA. 2013 Apr 3;309(13):1368-78. | |||
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.